Clinical trials · New York
Autism spectrum disorder clinical trials in New York
We’re tracking 14 recruiting autism spectrum disorder studies with a site in New York — including Phase 2, Phase 3 and Phase 4 studies, each written for real people, not researchers.
Recruiting studies in New York
- NCT06706674RecruitingPhase 3
Testing lumateperone for irritability in teens with autism
This study tests an investigational medication called lumateperone to see if it can reduce irritability in children and teens with autism. It is for teenagers aged 13–17 whose irritability is causing significant problems.
New York, New YorkAges 5–17 - NCT03492060Recruiting
Study of genetic variants in neurogenetic disorders over time
This study looks at how people’s genetic test results relate to health changes over time in conditions caused by gene differences. If you already have genetic confirmation of a disease-causing variant, you may be able to join.
New York, New YorkAges Any age - NCT04060030RecruitingPhase 2
Leucovorin for young children with autism language difficulties
This Phase 2 study tests whether leucovorin (a vitamin-related medicine) can improve social communication and language in young children with autism. It also looks at safety and whether the results hold while the child stays on their usual therapies and routines.
Brooklyn, New YorkAges 2.5 years–5 years - NCT04322734Recruiting
Blood tests study immune and metabolism markers in neurodevelopment
This study looks for biological “signals” in blood—related to the immune system and metabolism—to better understand conditions like autism and other brain or development-related disorders. It may help researchers find markers that could guide future diagnosis or treatment.
Brooklyn, New YorkAges Up to 18 years - NCT05916339RecruitingPhase 4
Managing ADHD symptoms in autistic children with a study plan
This Phase 4 study looks at how to manage ADHD symptoms in children and teens who also have autism. It may help your child’s care team learn what treatment routines work best in real life settings.
Rochester, New YorkAges 4–17 - NCT05999240RecruitingPhase 2
Pimavanserin for rigid-compulsive symptoms in autism
This trial tests if the drug pimavanserin can help reduce rigid or repetitive behaviors in people with autism spectrum disorder. It may be an option if you or your child struggle with these symptoms and want to try a new treatment.
White Plains, New YorkAges 12–40 - NCT06006637Recruiting
Measuring and reducing autism symptoms
This study tests a new platform designed to measure and reduce autism symptoms in children ages 2 to 8. It may help if your child has an autism diagnosis and is not taking psychiatric medications.
New York, New YorkAges 2–8 - NCT06229210RecruitingPhase 3
Lumateperone safety study for children with schizophrenia, bipolar, or autism
This trial tests a medication called lumateperone for children and teens with schizophrenia, bipolar disorder, or autism spectrum disorder. It aims to see if the medicine is safe and tolerable over time.
Staten Island, New YorkAges 5–17 - NCT07091279RecruitingPhase 2
Test of Propranolol for Severe Behaviors in Autism
This study tests a medication called propranolol to see if it can reduce aggression and other severe behaviors in adolescents and adults with autism. It might be an option if you have frequent and serious challenging behaviors that other treatments haven't helped.
White Plains, New YorkAges 12–40 - NCT07092280Recruiting
Brain stimulation study for children with autism
This trial tests if mild electrical stimulation applied to the head (tDCS) can help children with autism. Your child must be enrolled in ABA therapy and be off certain medications to join.
Staten Island, New YorkAges 5–12 - NCT07303907RecruitingPhase 2
DT402 trial for social & communication skills in autism
This trial tests an experimental drug called DT402 to see if it can improve social and communication skills in adults with autism. You may join if you are between 18 and 65, have a confirmed autism diagnosis, and have noticeable social challenges.
New York, New YorkAges 18–65 - NCT03202303RecruitingPhase 2
CBDV treatment study for children with autism irritability
This Phase 2 study tests CBDV, a form of cannabis-based medicine, compared with placebo (dummy medicine) in children with autism who have significant irritability and social challenges. It aims to see whether CBDV can improve behavior and overall symptom severity safely over the study period.
New York, New YorkAges 5–18 - NCT03718936Recruiting
Study of genetic ADNP conditions in children and adults
This study looks at how people with certain disease-causing changes in the ADNP gene function using medical, genetic, and thinking/behavior assessments. It may help doctors better understand the condition and tailor support for families.
New York, New YorkAges 2 years+ - NCT03718923Recruiting
Study for people with FOXP1 gene changes
This study looks at how people with FOXP1-related neurodevelopmental conditions work and how they’re affected, using genetic, medical, and thinking/learning tests. It may help researchers better understand the condition and improve future care.
New York, New YorkAges 2 years+
Autism spectrum disorder trials by city in New York
Where these studies are running in New York
Institutions with a site for the recruiting autism spectrum disorder studies listed above.
- Center for Autism and the Developing Brain · 2 studies
- New York State Institute for Basic Research · 2 studies
- Richmond Behavioral Associates · 2 studies
- State University of New York Downstate Medical Center · 2 studies
- The Seaver Autism Center for Research and Treatment · 2 studies
- Advantage Clinical Trials
- Columbia University Irving Medical Center
- Golisano Center for Special Needs
What taking part in a autism spectrum disorder study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Autism spectrum disorder trials in other states
Common questions
- Are there autism spectrum disorder clinical trials in New York?
- Yes. We're currently tracking 14 recruiting autism spectrum disorder studies with a site in New York, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a autism spectrum disorder study in New York?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in New York to take part?
- Not necessarily. These studies have a site in New York, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a autism spectrum disorder trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New autism spectrum disorder studies open in New York regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.